Andrew J Steele Selected Research

Agammaglobulinaemia Tyrosine Kinase

4/2019

Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew J Steele Research Topics

Disease

18	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022 - 03/2005
12	Neoplasms (Cancer) 01/2022 - 06/2011
4	Disease Progression 10/2021 - 01/2016
3	Lymphoma (Lymphomas) 01/2022 - 01/2017
1	Bites and Stings (Sting) 01/2017
1	Breast Neoplasms (Breast Cancer) 11/2016
1	Leukemia 11/2016
1	Carcinogenesis 01/2016
1	Lymphocytosis 06/2015
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Fibrosarcoma 01/2014
1	Hypoxia (Hypoxemia) 12/2006
1	Hematologic Neoplasms (Hematological Malignancy) 03/2005
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2005
1	Myeloid Leukemia (Leukemia, Myelocytic) 03/2005

Drug/Important Bio-Agent (IBA)

5	AntigensIBA 02/2022 - 04/2015
5	ibrutinibIBA 10/2021 - 01/2016
4	Phosphotransferases (Kinase)IBA 01/2022 - 07/2014
4	anti-IgMIBA 01/2019 - 01/2016
2	Immunoglobulin M (IgM)IBA 04/2019 - 11/2014
2	Biological ProductsIBA 01/2019 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2008
2	CytokinesIBA 01/2017 - 11/2010
2	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 11/2016 - 07/2014
2	Interleukin-4 (Interleukin 4)IBA 01/2016 - 11/2010
1	Proteasome InhibitorsIBA 01/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2022
1	CalciumIBA 01/2022
1	NexusIBA 09/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2019
1	serum P-component (CIt)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	4- (cyclopropylamino)- 2- ((4- (4- (ethylsulfonyl)piperazin- 1- yl)phenyl)amino)pyrimidine- 5- carboxamideIBA 05/2017
1	Janus Kinase InhibitorsIBA 05/2017
1	PhytochemicalsIBA 11/2016
1	phenethyl isothiocyanate (PEITC)IBA 11/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2016
1	Oncogene Proteins (Oncogene Protein)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	idelalisibIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2015
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 06/2015
1	Monoclonal AntibodiesIBA 06/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2015
1	LigandsIBA 04/2015
1	AutoantigensIBA 04/2015
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Immunoglobulins (Immunoglobulin)IBA 10/2011
1	Cytotoxins (Cytolysins)IBA 11/2010
1	PF 956980IBA 11/2010
1	2-phenylacetylenesulfonamideIBA 08/2009
1	combretastatinIBA 12/2006
1	Peptides (Polypeptides)IBA 03/2005
1	Indicators and Reagents (Reagents)IBA 03/2005

Therapy/Procedure

3	Therapeutics 01/2022 - 06/2011
1	Immunotherapy 01/2017